CasOT: a genome-wide Cas9/gRNA off-target searching tool.

Bioinformatics

Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education, State Key Laboratory of Protein and Plant Gene Research, Center for Bioinformatics, College of Life Sciences, Peking University, Beijing 100871, China and Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, CA 90095, USA.

Published: April 2014

Unlabelled: The CRISPR/Cas or Cas9/guide RNA system is a newly developed, easily engineered and highly effective tool for gene targeting; it has considerable off-target effects in cultured human cells and in several organisms. However, the Cas9/guide RNA target site is too short for existing alignment tools to exhaustively and effectively identify potential off-target sites. CasOT is a local tool designed to find potential off-target sites in any given genome or user-provided sequence, with user-specified types of protospacer adjacent motif, and number of mismatches allowed in the seed and non-seed regions.

Availability: http://eendb.zfgenetics.org/casot/ CONTACT: zfgenetics@gmail.com or bzhang@pku.edu.cn Supplementary Information: Supplementary data are available at Bioinformatics online.

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btt764DOI Listing

Publication Analysis

Top Keywords

cas9/guide rna
8
potential off-target
8
off-target sites
8
casot genome-wide
4
genome-wide cas9/grna
4
off-target
4
cas9/grna off-target
4
off-target searching
4
searching tool
4
tool unlabelled
4

Similar Publications

Targeted sequencing of bacteria using CRISPR-Cas9 enrichment and Oxford Nanopore Technologies.

mSystems

January 2025

Department of Infectious Diseases, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.

Unlabelled: Sequencing DNA directly from patient samples enables faster pathogen characterization compared to traditional culture-based approaches, but often yields insufficient sequence data for effective downstream analysis. CRISPR-Cas9 enrichment is designed to improve the yield of low abundance sequences but has not been thoroughly explored with Oxford Nanopore Technologies (ONT) for use in clinical bacterial epidemiology. We designed CRISPR-Cas9 guide RNAs to enrich the human pathogen , by targeting multi-locus sequence type (MLST) and transfer RNA (tRNA) genes, as well as common antimicrobial resistance (AMR) genes and the resistance-associated integron gene .

View Article and Find Full Text PDF

Trans-nuclei CRISPR/Cas9: safe approach for genome editing in the edible mushroom excluding foreign DNA sequences.

Appl Microbiol Biotechnol

December 2024

Graduate School of Agriculture, Kyoto University, Sakyo-Ku, Kitashirakawaoiwakecho, Kyoto, 606-8502, Japan.

Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9)-assisted genome editing has been applied to several major edible agaricomycetes, enabling efficient gene targeting. This method is promising for rapid and efficient breeding to isolate high-value cultivars and overcome cultivation challenges. However, the integration of foreign DNA fragments during this process raises concerns regarding genetically modified organisms (GMOs) and their regulatory restrictions.

View Article and Find Full Text PDF

Generation of recombinant vaccinia viruses opens many avenues for poxvirus research; however current methods for virus production can be laborious. Traditional methods rely on recombination strategies that produce engineered viruses at a low frequency, which then need to be identified and isolated from a large background of parent virus. For this reason, marker and reporter genes are often included, but in many cases these require removal in subsequent steps and the entire process is relatively inefficient.

View Article and Find Full Text PDF

Recent Advances and Prospects in RNA Drug Development.

Int J Mol Sci

November 2024

Department of Health Pharmacy, Yokohama University of Pharmacy, 601 Matano, Totsuka, Yokohama 245-0066, Japan.

Article Synopsis
  • RNA therapeutics have evolved significantly since the late 1970s, providing new treatment options for challenging diseases through modalities like ASOs, siRNAs, miRNAs, and mRNAs.
  • * The discovery of synthetic oligonucleotides and RNA interference laid the groundwork, while mRNA vaccines during the COVID-19 pandemic propelled interest in RNA-based therapies.
  • * Despite challenges such as stability and delivery, advancements in technology and AI are enhancing the field, with successes seen in treatments for specific genetic disorders and the potential for personalized medicine in the future.*
View Article and Find Full Text PDF

FastAd: A versatile toolkit for rapid generation of single adenoviruses or diverse adenoviral vector libraries.

Mol Ther Methods Clin Dev

December 2024

Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Adenoviruses (Ads) are potent gene delivery vectors for and applications. However, current methods for their construction are time-consuming and inefficient, limiting their rapid production and utility in generating complex genetic libraries. Here, we introduce FastAd, a rapid and easy-to-use technology for inserting recombinant "donor" DNA directly into infectious "receiver" Ads in mammalian cells by the concerted action of two efficient recombinases: Cre and Bxb1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!